FDA Approved: ALLOPURINOL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for allopurinol submitted by Mylan Pharmaceuticals Inc. (ANDA 018659).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

SUPPL AP for ALLOPURINOL (ALLOPURINOL)